| Primary |
| Hepato-lenticular Degeneration |
50.0% |
| Metabolic Disorder |
50.0% |
|
| Blood Creatine Phosphokinase Increased |
33.3% |
| Erythema |
33.3% |
| Medication Error |
33.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
55.6% |
| Hepato-lenticular Degeneration |
9.8% |
| Product Used For Unknown Indication |
6.0% |
| Pulmonary Arterial Hypertension |
3.8% |
| Asthma |
2.3% |
| Vitamin Supplementation |
2.3% |
| Anaemia |
1.5% |
| Arthritis |
1.5% |
| Blood Potassium Decreased |
1.5% |
| Crohn's Disease |
1.5% |
| Depression |
1.5% |
| Fluid Retention |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Gout |
1.5% |
| Heart Rate Decreased |
1.5% |
| Hypertension |
1.5% |
| Metastatic Malignant Melanoma |
1.5% |
| Nasopharyngitis |
1.5% |
| Thrombosis |
1.5% |
| Alopecia |
0.8% |
|
| Urticaria |
13.8% |
| Drug Hypersensitivity |
10.3% |
| Haematemesis |
10.3% |
| Mania |
6.9% |
| Tachycardia |
6.9% |
| Blood Creatine Phosphokinase Increased |
3.4% |
| Carpal Tunnel Syndrome |
3.4% |
| Crohn's Disease |
3.4% |
| Dizziness |
3.4% |
| Mental Status Changes |
3.4% |
| Metastases To Lung |
3.4% |
| Nasopharyngitis |
3.4% |
| Neoplasm Malignant |
3.4% |
| Neoplasm Progression |
3.4% |
| Open Wound |
3.4% |
| Parkinson's Disease |
3.4% |
| Pulmonary Oedema |
3.4% |
| Superinfection |
3.4% |
| Urinary Tract Infection |
3.4% |
| Urine Copper Increased |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.2% |
| Drug Use For Unknown Indication |
24.2% |
| Hypertension |
3.6% |
| Prophylaxis |
3.4% |
| Rheumatoid Arthritis |
3.3% |
| Vitamin Supplementation |
3.3% |
| Supplementation Therapy |
2.9% |
| Crohn's Disease |
2.5% |
| Pain |
2.4% |
| Depression |
2.4% |
| Medical Diet |
2.1% |
| Blood Cholesterol Increased |
1.7% |
| Multiple Myeloma |
1.6% |
| Osteoporosis |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Mineral Supplementation |
1.4% |
| Asthma |
1.4% |
| Diabetes Mellitus |
1.3% |
| Arthritis |
1.2% |
| Insomnia |
1.1% |
|
| Vomiting |
14.9% |
| Weight Decreased |
7.9% |
| Pruritus |
6.1% |
| Weight Increased |
5.9% |
| Flushing |
5.4% |
| Paraesthesia |
5.2% |
| Drug Ineffective |
4.9% |
| Nausea |
4.7% |
| Urticaria |
4.7% |
| Pain |
4.5% |
| Urinary Tract Infection |
4.1% |
| Pneumonia |
4.0% |
| Vision Blurred |
4.0% |
| Death |
3.8% |
| Rash |
3.6% |
| Headache |
3.4% |
| Injection Site Pain |
3.4% |
| Somnolence |
3.4% |
| Diarrhoea |
3.1% |
| Fatigue |
3.1% |
|
